HOME >> BIOLOGY >> NEWS
Winner of 2004 EMBO Science Writing Prize announced

The EMBO Science Writing Prize is awarded annually for an outstanding piece of science writing that effectively communicates a topical issue to a non-scientific audience. Matthew Bottomley's innovative text fulfils this criterion on every level. The lively dialogue relates double agent James Pond's mission to combat the deadly 'Pseudo' bacteria currently a leading cause of hospital-acquired infections. Set in Hawaii, the exotic tale tells how Pond stumbles across the phenomenon of the glowing Bobtail Squid and learns how its quorum-sensing technology can be used in the fight against the Pseudo bacteria.

English-born, Matthew Bottomley currently lives and works in Rome, Italy. His research at the Istituto di Ricerche di Biologia Molecolare focuses on biophysical studies of protein structures involved in chromatin structure or transcription. The young researcher's first post-doctoral position at EMBL in Heidelberg was supported by an EMBO Long-Term Fellowship.

Asked to elaborate on the inspiration behind his text, Bottomley commented that he had long been looking for an appropriate medium to communicate this fascinating story. "It was really my brother-in-law who gave me the James Bond idea. After hearing the whole bizarre story of the glowing squid, his immediate response was that it sounded like a scene from a James Bond film. That was it James Pond was born and it was then a race against time (very Bond-like) to write the article before the deadline expired!"

The prize and award of 1,500 Euro will be presented to the winner at the EMBO Members Meeting in October of this year.


'"/>

Contact: Andrew Moore
andrew.moore@embo.org
49-6221-8891-109
European Molecular Biology Laboratory
30-Aug-2004


Page: 1

Related biology news :

1. Secretary of Energy announces seven E.O. Lawrence Award Winners
2. Winners of the DFG Bioinformatics Initiative
3. Leibniz Prize Winners 1999 - Most Highly Endowed German Promotional Prize For Ten Scientists
4. AAAS Announces The Winners Of Its Science Journalism Awards
5. AAAS Announces Science Journalism Award Winners
6. A long-necked sea predator from China described in Science
7. Brown ecologist garners major National Science Foundation grant
8. Popular Science announces Third Annual Brilliant 10
9. Study in Science reveals recreational fishing takes big bite of ocean catch
10. New paper in Science introduces revolutionary new paradigm for fishery management
11. Articles on forest fire risks published in BioScience

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Winner EMBO Science Writing Prize announced

(Date:12/10/2014)... 9, 2014 CIE San Diego has launched ... the connective tissue that enhances care coordination among social ... share client-level information; earned a second $1 million grant ... serving seniors aging in community and; will be recognized ... 11 th 4-6p. CIE San Diego ...
(Date:12/4/2014)... PALM BEACH GARDENS, Fla. , Dec. 3, ... identity management solutions, today announced that its DigitalPersona ... 4500 fingerprint readers have been deployed throughout ... Carolina , South Carolina ... network headquartered in Southern Pines, North ...
(Date:11/21/2014)... 20, 2014 Strict laws against distracted driving ... the North American and European automotive sector towards gesture ... recognition systems that are intuitive and able to retrieve ... industry. New analysis from Frost & ... in Europe and ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4
(Date:12/19/2014)... BURLINGTON, Mass. , Dec. 18, 2014  Decision ... dental biomaterial market will grow moderately through ... implant procedures and growing awareness of dental biomaterials all ... underdeveloped markets such as China ... incomes will bring dental procedures within reach for a ...
(Date:12/17/2014)... New York, NY (PRWEB) December 16, 2014 ... undergone significant changes since 2013, which is why IBISWorld ... one, this industry continues to benefit from an intensified ... 2014, the proposal for new emission standards for power ... affected industry operators. According to IBISWorld Industry Analyst Sarah ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Ipsen ... IPN; ADR: IPSEY), today announced that ... to as Somatuline®) was approved by the U.S. ... of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients ... or metastatic disease to improve progression-free survival (PFS). ...
(Date:12/17/2014)... December 17, 2014 Gene synthesis ... it has entered into a technology access and ... to apply DNA2.0’s proprietary protein engineering technology, known ... , “We are extremely excited that the global ... This proprietary bioengineering technology has now been ...
Breaking Biology Technology:Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2
Cached News: